2-(6,7-Dihydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid | 388119-13-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 2-(6,7-Dihydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid
• 英文别名: 2-(6,7-dihydroxy-4-methyl-2-oxochromen-3-yl)acetic acid
• CAS: 388119-13-9
• 化学式: C₁₂H₁₀O₆
• mdl: MFCD08741827
• 分子量: 250.2
• InChiKey: DKELHZLAKMOKAR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT

文献信息

• Coumarin derivatives with comt inhibiting activity
  申请人：——

  公开号：US20030186975A1

  公开（公告）日：2003-10-02

  Compounds of formula (I′) wherein the two OH— substituents in the phenyl moiety are in a position ortho to one another and R1 in a position ortho to one of the hydroxy groups; and X, R 1 to R 6 are as defined in claims, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.

  式(I')的化合物，其中苯基上的两个OH-取代基相对位于邻位，R1位于其中一个羟基的邻位；并且X，R1到R6如权利要求所定义的，表现出COMT酶抑制活性，因此它们可用作COMT抑制剂。
• COUMARIN DERIVATIVES WITH COMT INHIBITING ACTIVITY
  申请人：ORION CORPORATION

  公开号：EP1301503A1

  公开（公告）日：2003-04-16
• US6951870B2
  申请人：——

  公开号：US6951870B2

  公开（公告）日：2005-10-04
• [EN] COUMARIN DERIVATIVES WITH COMT INHIBITING ACTIVITY<br/>[FR] DERIVES DE COUMARINE AYANT UNE ACTIVITE D'INHIBITION DE LA COMT
  申请人：ORION CORP

  公开号：WO2002002548A1

  公开（公告）日：2002-01-10

  Compounds of formula (I') wherein the two OH- substituents in the phenyl moiety are in a position ortho to one another and R1 in a position ortho to one of the hydroxy groups; and X, R1 to R6 are as defined in claims, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.
• [EN] COFLUORONS AND METHODS OF MAKING AND USING THEM<br/>[FR] COFLUORONS ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：UNIV CORNELL

  公开号：WO2012154213A1

  公开（公告）日：2012-11-15

  The present invention is directed to method of using a collection of monomers capable of forming multimers as a fluorescence reporter in different applications such as ligand detection/screening, disease diagnosis, drug discovery or screening, fluorescent labeling and imaging, or other fluorescent methodologies. Each monomer in the collection includes one or more ligand elements useful for binding to a target molecule with a dissociation constant of less than 300 μΜ and a linker element connected to the ligand elements directly or indirectly through a connector. Association of linker elements of different combinations of monomers, with their ligand elements bound to the target molecule to form a multimer, will generate a unique fluorescent signature different from that produced by those monomers either alone or in association with each other in the absence of the target molecule, when subjected to electromagnetic excitement.